Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Blood (2018) 132 (Supplement 1): 3354.

https://doi.org/10.1182/blood-2018-99-110980

Published: 2018

Journal Articles

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Olga Moser, MD, Arnaud Dalissier, PhD, Eric Beohou, Wilhelm Woessmann, MD, Birgit Burkhardt, MD PhD, Karin Mellgren, MD PhD, Peter Bader, MD PhD, Andre Manfred Willasch, MD, Udo Kontny, MD

Blood (2018) 132 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2018-99-116809

Published: 2018

Journal Articles

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

Birgit Burkhardt, MD, PhD, Deniz Yavuz, Martin Zimmerman, PhD, Jutta Schieferstein, Edita Kabickova, MD, Andishe Attarbaschi, MD, Jasmin Lisfeld, MD, Bettina R. Bonn, PhD, Alfred Reiter, MD, Christine Damm-Welk, PhD

Blood (2012) 120 (21): 1547.

https://doi.org/10.1182/blood.V120.21.1547.1547

Published: 2012

Journal Articles

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Birgit Burkhardt, MD, PhD, Ilske Oschlies, MD, Wolfram Klapper, MD, PhD, Martin Zimmermann, PhD, Andrea Meinhardt, MD, Eva Landmann, MD, Wilhelm Woessmann, MD, PhD, Georg Mann, MD, Felix Niggli, MD, Martin Schrappe, MD, PhD, Alfred Reiter, MD, PhD

Blood (2009) 114 (22): 102.

https://doi.org/10.1182/blood.V114.22.102.102

Published: 2009

Journal Articles

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Birgit Burkhardt, MD, PhD, Alfred Reiter, MD, Eva Landmann, MD, Peter J. Lang, MD, Lisa Lassay, MD, Roswitha Dickerhoff, MD, Max Lakomek, MD, Guenter Henze, MD, Arend von Stackelberg, MD

Blood (2008) 112 (11): 3589.

https://doi.org/10.1182/blood.V112.11.3589.3589

Published: 2008

Journal Articles

Pediatric T-Cell Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: One and the Same or Two Different Diseases?.

David Krieger, Anja Moericke, MD, Wolfram Klapper, MD, Franziska Greene, Martin Zimmermann, PhD, Martin Schrappe, MD, Alfred Reiter, MD, Birgit Burkhardt, MD, PhD

Blood (2007) 110 (11): 1437.

https://doi.org/10.1182/blood.V110.11.1437.1437

Published: 2007

Journal Articles

Pediatric T-Cell Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: Differences in the Common Deleted Region and the Prognostic Impact of Chromosome 6q Deletions.

Birgit Burkhardt, MD, Anja Moericke, MD, Wolfram Klapper, MD, Franziska Mueller, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2006) 108 (11): 294.

https://doi.org/10.1182/blood.V108.11.294.294

Published: 2006

Journal Articles

Secondary Neoplasms Subsequent to Berlin-Frankfurt-Muenster (BFM) Therapy of Non-Hodgkin Lymphoma of Childhood: Significantly Higher Risk for Patients with Lymphoblastic Lymphoma Compared to Other NHL-Subtypes.

Olga Wachowski, MD, Martin Zimmermann, PhD, Birgit Burkhardt, MD, Olaf Determann, MD, Ulrike Meyer, Peter Kaatsch, PhD, Georg Mann, MD, Reza Parwaresch, MD, Hansjoerg Riehm, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2005) 106 (11): 232.

https://doi.org/10.1182/blood.V106.11.232.232

Published: 2005

Journal Articles

CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient’s Outcome Differ According to the Subtype.

Janina Salzburg, MD, Birgit Burkhardt, MD, Olga Wachowski, MD, Martin Zimmermann, PhD, Reza Parwaresch, MD, Wolf-Dieter Ludwig, MD, Georg Mann, MD, Felix Niggli, MD, Hansjörg Riehm, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2005) 106 (11): 233.

https://doi.org/10.1182/blood.V106.11.233.233

Published: 2005

Journal Articles

Loss of Heterozygosity on Chromosome 6q14-q24 Confers Poor Outcome on Children and Adolescents with T-Cell Lymphoblastic Lymphoma.

Birgit Burkhardt, MD, Jochen Bruch, PhD, Franziska Mueller, Janina Salzburg, MD, Jochen Harbott, PhD, Alfred Reiter, MD

Blood (2005) 106 (11): 2809.

https://doi.org/10.1182/blood.V106.11.2809.2809

Published: 2005

Journal Articles

Time to Failure and CD3-Expression Are Strong Prognostic Factors in Relapsed Anaplastic Large Cell Lymphoma of Childhood and Adolescence.

Wilhelm Woessmann, MD, Meike Lenhard, Christina Peters, MD, Birgit Burkhardt, MD, Wolgang Ebell, MD, Thomas Klingebiel, MD, Georg Mann, MD, Johann Greil, MD, Karl-Walter Sykora, MD, Dirk Janssen, MD, Martin Zimmermann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2005) 106 (11): 3327.

https://doi.org/10.1182/blood.V106.11.3327.3327

Published: 2005

NARROW

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Pediatric T-Cell Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: One and the Same or Two Different Diseases?.

Pediatric T-Cell Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma: Differences in the Common Deleted Region and the Prognostic Impact of Chromosome 6q Deletions.

Secondary Neoplasms Subsequent to Berlin-Frankfurt-Muenster (BFM) Therapy of Non-Hodgkin Lymphoma of Childhood: Significantly Higher Risk for Patients with Lymphoblastic Lymphoma Compared to Other NHL-Subtypes.

CNS Involvement in Childhood and Adolescence Non-Hodgkin Lymphoma: Prevalence and Patient’s Outcome Differ According to the Subtype.

Loss of Heterozygosity on Chromosome 6q14-q24 Confers Poor Outcome on Children and Adolescents with T-Cell Lymphoblastic Lymphoma.

Time to Failure and CD3-Expression Are Strong Prognostic Factors in Relapsed Anaplastic Large Cell Lymphoma of Childhood and Adolescence.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only